Mycophenolate mofetil

ATC Code L04AA06

Mycophenolate mofetil

Definition

The morpholinoethyl ester of mycophenolic acid (MPA) with potent immunosuppressive properties. Mycophenolate stops T-cell and B-cell proliferation through selective inhibition of the de novo pathway of purine biosynthesis. In vivo, the active metabolite, MPA, reversibly inhibits inosine 5'-monophosphate dehydrogenase, an enzyme involved in the de novo synthesis of guanine nucleotides. MPA displays high lymphocyte specificity and cytotoxicity due to the higher dependence of activated lymphocytes on both salvage and de novo synthesis of guanine nucleotides relative to other cell types. (NCI04)

Also known as CellCept, MMF, MYCOPHENOLATE MOFETIL — per NCIT

Also identified as

Indications

Disease Relation Source
Graft versus host disease may prevent MEDRT · Public domain (U.S. Government work)
Graft versus host disease may treat MEDRT · Public domain (U.S. Government work)
Psoriasis may treat MEDRT · Public domain (U.S. Government work)

Organ Effects

Organ Side effect / interaction Source
Skin of body may treat a disease of this organ DERIVED · CC BY 4.0

1 entry above is marked DERIVED: Atlas Médico inferred it by combining two sourced claims, and no source asserts this link directly. Treat it as a navigation aid, not as a clinical statement.